STAT1 activation in association with JAK2 exon 12 mutations.

Address: Cambridge Institute for Medical Research and Wellcome Trust/MRC Stem Cell Institute, University of Cambridge, UK Department of Haematology, Addenbrooke's Hospital, UK Department of Haematology, University of Cambridge, Cambridge, UK.; Cambridge Institute for Medical Research and Wellcome Trust/MRC Stem Cell Institute, University of Cambridge, UK Department of Haematology, University of Cambridge, Cambridge, UK.; Hematology Department, Hospital del Mar-IMIM, Barcelona, Spain.; Department of Experimental and Clinical Medicine, University of Florence and Azienda Ospedaliera Universitaria Careggi, Florence, Italy.; Department of Haematology, Guy's and St Thomas' NHS Foundation Trust, London, UK.; Department of Haematology, Royal Hallamshire Hospital, Sheffield, UK.; University Hospital of Ulm, Department of Internal Medicine III, Germany.; Institut Bergonie, Department of Hematology, Bordeaux, France.; Laboratoire d'Hematologie, CHU de Bordeaux and Laboratorie Hematopoiese Leucemique et Cibles Thérapeutiques, INSERM U 1035, Universite Bordeaux Segalen, Bordeaux, France.; University of Bordeaux, Etablissement Français du Sang, France.; Cambridge Institute for Medical Research and Wellcome Trust/MRC Stem Cell Institute, University of Cambridge, UK Department of Haematology, Addenbrooke's Hospital, UK Department of Haematology, University of Cambridge, Cambridge, UK [email protected].